[Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000787:Angina Pectoris / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010417:Pentaerythritol Tetranitrate / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents; D010417:Pentaerythritol Tetranitrate
L'utilizzazione clinica di un farmaco ad associazioni butidrinapentaeritrite nella insufficienza coronarica.